GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,599.00p
   
  • Change Today:
      15.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,114.88m
  • Volume: 3,934,406
  • Market Cap: £65,797m
  • RiskGrade: 129

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing Operations          
Revenue 14,129.00 14,119.00 10,993.00 16,714.00 15,470.00
Operating Profit/(Loss) 4,223.00 3,374.00 2,485.00 4,864.00 2,912.00
Profit Before Tax 3,892.00 2,990.00 2,104.00 4,476.00 2,559.00
Profit After Tax 3,376.00 2,517.00 2,150.00 4,119.00 2,035.00
Discontinued Operations          
Profit After Tax n/a 625.00 648.00 n/a n/a
PROFIT FOR THE PERIOD 3,376.00 3,142.00 2,798.00 4,119.00 2,035.00
           
Continuing EPS          
Earnings per Share - Basic 76.90p 68.50p 50.30p 77.00p 36.30p
Earnings per Share - Diluted 76.20p 67.88p 49.90p 77.00p 36.30p
Earnings per Share - Adjusted 75.80p 83.75p 49.30p 56.90p 60.60p
Continuing and Discontinued EPS          
Earnings per Share - Basic 76.90p 82.12p 61.70p 77.00p 36.30p
Earnings per Share - Diluted 76.20p 81.25p 61.20p 77.00p 36.30p
Earnings per Share - Adjusted 75.80p 83.75p 49.30p 56.90p 60.60p
Dividend per Share 28.00p 37.81p 38.00p 38.00p 38.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Total Non-Current Assets 40,113.00 34,857.00 59,445.00 61,662.00 45,404.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 59,461.00 89,045.00 77,011.00 84,640.00 63,632.00
Total Liabilities 47,302.00 66,405.00 55,433.00 64,503.00 60,665.00
Net Assets 12,159.00 22,640.00 21,578.00 20,137.00 2,967.00
           
Shareholders Funds 12,691.00 16,374.00 15,377.00 13,593.00 3,614.00
Minority Interests/Other Equity (532.00) 6,266.00 6,201.00 6,544.00 (647.00)
Total Equity 12,159.00 22,640.00 21,578.00 20,137.00 2,967.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page